Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc.

Overview
Date Founded

2015

Headquarters

260 Littlefield Avenue, South San Francisco, CA, 94080, USA

Type of Company

Public

Employees (Worldwide)

78

Industries

Biotechnology
Human Resources & Personnel Services
IT Consulting & Services
Hospitals & Patient Services
Pharmaceuticals
Medical Support Services

Company Description

Pliant Therapeutics, Inc. engages in the business of developing and commercializing novel therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. Pliant Therapeutics was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.

Contact Data
Trying to get in touch with decision makers at Pliant Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Scientific Founder

Scientific Founder

Scientific Founder

Scientific Founder

President & Chief Executive Officer

Chief Financial Officer

Chief Business Officer

Chief Medical Officer

Chief Human Resource Officer

Vice President, Non-Clinical Development

Board of Directors

Former Interim Executive Chairman at Geron Corp.

President at International Council of Ophthalmology Foundation

Partner at Third Rock Ventures LLC

Partner at Third Rock Ventures LLC

Chief Executive Officer, President & Director at Tiaki Therapeutics, Inc.

Former President at Schering-Plough Biopharma

President & Chief Executive Officer at Pliant Therapeutics, Inc.

Operational Business Consultant at Warburg Pincus LLC

Chief Financial & Business Officer at ProQR Therapeutics NV

Paths to Pliant Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Pliant Therapeutics, Inc.
Owners & Shareholders
Details Hidden

Third Rock Ventures invests in companies located in the US. The firm targets operating in the fields of healthcare sector. It provides financing for early-stage capital requirements. It also acts as a lead investor.

Details Hidden

Redmill invests in US and non-US healthcare companies. They may also invest in fields related to healthcare where due diligence shows those healthcare assets are the driving force behind value creation and in other sectors from time to time. The firm uses the fundamental research as part of their investment process. Their protocols include company financial models, market models, investment theses, and regular dialogue. Redmill’s sources include contacts with physicians, focus outside US, dialogue with companies, attendance at medical conferences; meetings with private companies, and regular dialogue within the team.

Details Hidden

Part of Cowen, Inc., CHI Advisors LLC is an American company located in New York, NY, that provides investment advice. It was founded in 2002. Jeffrey Marc Solomon is currently the CEO of the firm.

Recent Transactions
Details Hidden

Pliant Therapeutics, Inc. issued USD Common Stock

Details Hidden

Pliant Therapeutics, Inc. issued Up to USD Common Stock

Details Hidden

Pliant Therapeutics, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
Details Hidden
Transaction Advisors
Escrow Agent

Advised onPliant Therapeutics, Inc. issued USD Common Stock

Underwriter

Advised onPliant Therapeutics, Inc. issued USD Common Stock

Auditor

Advised onPliant Therapeutics, Inc. issued USD Common Stock

Attorney

Advised onPliant Therapeutics, Inc. issued USD Common Stock

Attorney

Advised onPliant Therapeutics, Inc. issued USD Common Stock

Associate

Advised onPliant Therapeutics, Inc. issued USD Common Stock

Advisors & Consultants
Advisor

Managing Director at The Goldman Sachs Group, Inc.

Advisor

Account Manager at Canale Communications, Inc.

Key Stats and Financials As of 2020
Market Capitalization
$1.32B
Total Enterprise Value
$531M
Earnings Per Share
$-1.17
Revenue
$41.8M
Net Profit
$-41.5M
Total Equity
$283M
EBITDAMargin
-96.46%
EBITDA
$-40.3M
Total Debt
$0
Enterprise Value / Sales
12.7x
TEVNet Income
-12.78x
Debt TEV
0x
Non-Profit Donations & Grants
Investors
Details Hidden

Third Rock Ventures invests in companies located in the US. The firm targets operating in the fields of healthcare sector. It provides financing for early-stage capital requirements. It also acts as a lead investor.

Details Hidden

Eventide uses values-based analyses and fundamental, technical and risk analyses in selecting and recommending securities for investment. The firm also engages with sub-advisers concerning values-based criteria in connection with fixed-income securities held by certain Funds. Their investment process begins with a top-down analysis to select a variety of asset classes and/or sectors believed to offer opportunities for current income and/or capital appreciation. Eventide manages portfolios actively and this may involve frequent trading that negatively affects investment performance and increases transaction costs and taxes.

Details Hidden

S-Cubed Capital is an active manager which investment opportunities in companies located in the US. The firm targets companies operating across a broad range of sectors such as technology, financial asset management, sports management, agribusiness, philanthropy and real estate.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Pliant Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Pliant Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Pliant Therapeutics, Inc..